Nonalcoholic steatohepatitis will pose clinical, economic burden
Nonalcoholic steatohepatitis (NASH) is expected to pose a significant clinical and economic burden during the next 20 years for U.S.
Read more
Nonalcoholic steatohepatitis (NASH) is expected to pose a significant clinical and economic burden during the next 20 years for U.S.
Read moreOestrogens found naturally in cows’ milk are likely to be safe for human consumption in adults, according to a new
Read moreZika virus could pose a far greater threat to pregnancy than recent studies of miscarriage and stillbirth in human infections
Read more